Bacterial Profile, Antibiotic Resistance Pattern and Associated Factors Among Cancer Patients at University of Gondar Hospital, Northwest Ethiopia

Overview

Journal Infect Drug Resist

Publisher Dove Medical Press

Date 2018 Dec 7

PMID 30519054

Citations 18

Authors

Alelign Fentie

Yitayih Wondimeneh

Abera Balcha

Anteneh Amsalu

Birhanemeskel Tegene Adankie

Affiliations

Soon will be listed here.

Abstract

Introduction: Cancer is alarmingly increased in developing countries like Ethiopia, where multidrug resistant bacterial infection is rampant. The aim of this study was to determine the bacterial profile, antimicrobial resistance pattern, and associated factors among cancer patients attending University of Gondar Hospital.

Methods: A consecutive 216 cancer patients were recruited from February to April, 2017. Socio-demographic and clinical data were collected using a structured questionnaire. Culture and antibiotic resistance were done following standard microbiological procedures.

Result: The overall prevalence of bacterial infection was 19.4%. The predominant bacterial isolates were (28.6%), followed by coagulase negative staphylococci (26.2%) and (21.4%). Multidrug resistance was detected in 46.5% bacterial isolates. Methicillin resistance was detected in 25% of and in 45.5% of coagulase negative staphylococci. Fluoroquinolone resistance was detected in 33.3% of isolates. Cancer patients with solid tumor, started cancer therapy, and being symptomatic had higher odds of culture positivity.

Conclusion: The overall burden of bacterial infection among cancer patients is considerably high. The findings of this study inform baseline information for policymakers and call for additional studies with large isolates in different cancer treatment centers in the region and in the country to better understand the bacterial isolate and resistance pattern.

Citing Articles

CTX-M, TEM, and SHV Genes in , and Isolated from Hematologic Cancer Patients with Bacteremia in Uganda.

Lubwama M, Kateete D, Katende G, Kigozi E, Orem J, Phipps W Infect Drug Resist. 2024; 17:641-653.

PMID: 38384499 PMC: 10878986. DOI: 10.2147/IDR.S442646.

Phenotypic Bacterial Isolates, Antimicrobial Susceptibility pattern and Associated factors among Septicemia Suspected Patients at a hospital, in Northwest Ethiopia: Prospective cross-sectional study.

Belew H, Tamir W, Dilnessa T, Mengist A Ann Clin Microbiol Antimicrob. 2023; 22(1):47.

PMID: 37349767 PMC: 10288695. DOI: 10.1186/s12941-023-00599-7.

Clinical outcomes of antimicrobial resistance in cancer patients: a systematic review of multivariable models.

Danielsen A, Franconeri L, Page S, Myhre A, Tornes R, Kacelnik O BMC Infect Dis. 2023; 23(1):247.

PMID: 37072711 PMC: 10114324. DOI: 10.1186/s12879-023-08182-3.

Extended-spectrum beta-lactamase-producing Enterobacteriaceae related urinary tract infection in adult cancer patients: a multicenter retrospective study, 2015-2019.

Wang G, Zhu Y, Feng S, Wei B, Zhang Y, Wang J BMC Infect Dis. 2023; 23(1):129.

PMID: 36879210 PMC: 9987039. DOI: 10.1186/s12879-023-08023-3.

Colibactin possessing E. coli isolates in association with colorectal cancer and their genetic diversity among Pakistani population.

Tariq H, Noreen Z, Ahmad A, Khan L, Ali M, Malik M PLoS One. 2022; 17(11):e0262662.

PMID: 36367873 PMC: 9651576. DOI: 10.1371/journal.pone.0262662.

References

Manafu E, Filimon R, Jari I, Petrariu F, Manole A . Clinical epidemiological study on the incidence of Escherichia coli infections in the cancer patients admitted to Surgery Department II of the Iasi Regional Oncology Institute in 2013. Rev Med Chir Soc Med Nat Iasi. 2014; 118(3):796-800. View

Sirkhazi M, Sarriff A, Aziz N, Almana F, Arafat O, Shorman M . Bacterial Spectrum, Isolation Sites and Susceptibility Patterns of Pathogens in Adult Febrile Neutropenic Cancer Patients at a Specialist Hospital in Saudi Arabia. World J Oncol. 2017; 5(5-6):196-203. PMC: 5649767. DOI: 10.14740/wjon850w. View

BAUER A, KIRBY W, SHERRIS J, Turck M . Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966; 45(4):493-6. View

Tanwar J, Das S, Fatima Z, Hameed S . Multidrug resistance: an emerging crisis. Interdiscip Perspect Infect Dis. 2014; 2014:541340. PMC: 4124702. DOI: 10.1155/2014/541340. View

Freifeld A, Bow E, Sepkowitz K, Boeckh M, Ito J, Mullen C . Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2011; 52(4):e56-93. DOI: 10.1093/cid/cir073. View

GEyesus T, Moges F, Eshetie S, Yeshitela B, Abate E . Bacterial etiologic agents causing neonatal sepsis and associated risk factors in Gondar, Northwest Ethiopia. BMC Pediatr. 2017; 17(1):137. PMC: 5461759. DOI: 10.1186/s12887-017-0892-y. View

Gaytan-Martinez J, Avila-Moran M, Mata-Marin J, Mateos-Garcia E, Fuentes-Allen J, Vela-Ojeda J . [Prevalence of bacterial infections and patterns of bacterial susceptibility among patients with fever, neutropenia, and hematological neoplasias]. Gac Med Mex. 2011; 147(4):325-32. View

Maschmeyer G, Haas A . The epidemiology and treatment of infections in cancer patients. Int J Antimicrob Agents. 2007; 31(3):193-7. DOI: 10.1016/j.ijantimicag.2007.06.014. View

Zembower T . Epidemiology of infections in cancer patients. Cancer Treat Res. 2014; 161:43-89. PMC: 7120867. DOI: 10.1007/978-3-319-04220-6_2. View

10.

Walwyn M, Nicholson A, Lee M, Wharfe G, Frankson M . Febrile neutropaenia in cancer patients. West Indian Med J. 2011; 59(2):209-14. View

11.

Magiorakos A, Srinivasan A, Carey R, Carmeli Y, Falagas M, Giske C . Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2011; 18(3):268-81. DOI: 10.1111/j.1469-0691.2011.03570.x. View

12.

Velez Echeverri C, Serna-Higuita L, Serrano A, Ochoa-Garcia C, Rojas Rosas L, Bedoya A . Resistance profile for pathogens causing urinary tract infection in a pediatric population, and antibiotic treatment response at a university hospital, 2010-2011. Colomb Med (Cali). 2014; 45(1):39-44. PMC: 4045227. View

13.

Homsi J, Walsh D, Panta R, Lagman R, Nelson K, Longworth D . Infectious complications of advanced cancer. Support Care Cancer. 2000; 8(6):487-92. DOI: 10.1007/s005200000143. View

14.

Gudiol C, Bodro M, Simonetti A, Tubau F, Gonzalez-Barca E, Cisnal M . Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients. Clin Microbiol Infect. 2012; 19(5):474-9. DOI: 10.1111/j.1469-0691.2012.03879.x. View

15.

Chong Y, Yakushiji H, Ito Y, Kamimura T . Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignancies. Int J Infect Dis. 2011; 15(4):e277-81. DOI: 10.1016/j.ijid.2010.12.010. View

16.

Eshetie S, Tarekegn F, Moges F, Amsalu A, Birhan W, Huruy K . Methicillin resistant Staphylococcus aureus in Ethiopia: a meta-analysis. BMC Infect Dis. 2016; 16(1):689. PMC: 5117566. DOI: 10.1186/s12879-016-2014-0. View

17.

Bow E . Fluoroquinolones, antimicrobial resistance and neutropenic cancer patients. Curr Opin Infect Dis. 2011; 24(6):545-53. DOI: 10.1097/QCO.0b013e32834cf054. View

18.

Al-Mulla N, Taj-Aldeen S, El Shafie S, Janahi M, Al-Nasser A, Chandra P . Bacterial bloodstream infections and antimicrobial susceptibility pattern in pediatric hematology/oncology patients after anticancer chemotherapy. Infect Drug Resist. 2014; 7:289-99. PMC: 4226521. DOI: 10.2147/IDR.S70486. View

19.

Montassier E, Batard E, Gastinne T, Potel G, de La Cochetiere M . Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance. Eur J Clin Microbiol Infect Dis. 2013; 32(7):841-50. DOI: 10.1007/s10096-013-1819-7. View

20.

Thom K, Kleinberg M, Roghmann M . Infection prevention in the cancer center. Clin Infect Dis. 2013; 57(4):579-85. PMC: 3726067. DOI: 10.1093/cid/cit290. View